Skip to content
Clinical Trials – home

Terlipressin Acetate: A Comprehensive Guide for Patients

0 / 2
trials open to patients / all trials
3+
Countries

In short

Terlipressin Acetate is a drug being studied in clinical trials for its potential benefits in treating cirrhosis, portal hypertension, and related complications such as refractory ascites. These trials aim to evaluate the safety, efficacy, and hemodynamic effects of Terlipressin when administered through different methods, including continuous infusion and bolus injection. The research focuses on how this medication impacts various aspects of liver and kidney function in patients with these conditions.

At a glance

Drug Name
Terlipressin Acetate
Conditions Studied
Cirrhosis, Portal Hypertension, Refractory Ascites
Administration Methods
Continuous infusion, Intravenous bolus injection
Primary Outcomes Measured
Safety, Efficacy, Blood flow changes, Portal pressure changes
Secondary Outcomes
Changes in paracentesis requirements, Blood flow in various organs
Study Designs
Open-label prospective study, Exploratory hemodynamic study
Comparison Drug
Serelaxin (RLX030) in one study
Treatment Duration
Varies from acute responses (hours) to extended treatment (28 days)

What is Terlipressin Acetate?

Terlipressin acetate, also known simply as terlipressin, is a medication used in the treatment of certain liver-related conditions. It belongs to a class of drugs called vasopressin analogues, which means it works similarly to a hormone naturally produced in the body called vasopressin. This hormone helps regulate blood pressure and water retention in the body.

Medical Conditions Treated with Terlipressin

Terlipressin is primarily used to treat complications associated with liver diseases. The main conditions it's used for include:

  • Cirrhosis with refractory ascites: Cirrhosis is a condition where the liver becomes scarred and damaged. Refractory ascites is a complication of cirrhosis where fluid builds up in the abdomen and doesn't respond well to standard treatments.
  • Portal hypertension: This is high blood pressure in the portal vein, which carries blood from the digestive organs to the liver. It's often a complication of cirrhosis.

How is Terlipressin Administered?

Terlipressin can be administered in different ways, depending on the specific treatment plan and clinical trial:

  1. Continuous infusion: In some cases, terlipressin is given as a continuous infusion using an ambulatory pump. This means the medication is slowly and steadily delivered into your bloodstream over an extended period, typically several days or weeks.
  2. Intravenous (IV) bolus injection: In other cases, terlipressin may be given as a single dose injected directly into a vein.

Current Clinical Trials and Research

Terlipressin is currently being studied in various clinical trials to better understand its effects and potential uses. Some of the ongoing research includes:

  • A study on low-dose continuous infusion of terlipressin in patients with cirrhosis and refractory ascites. This trial aims to determine if terlipressin can help manage ascites and reduce the need for procedures to remove excess fluid from the abdomen.
  • An exploratory study investigating the effects of terlipressin on blood flow in various organs, including the liver and kidneys, in patients with compensated cirrhosis and portal hypertension.

Effects of Terlipressin on the Body

Terlipressin works by affecting blood flow in various parts of the body. Some of its effects include:

  • Reducing portal pressure: Terlipressin can help lower the pressure in the portal vein, which may help manage complications of portal hypertension.
  • Affecting renal (kidney) blood flow: Research is being conducted to understand how terlipressin impacts blood flow to the kidneys.
  • Impacting hepatic (liver) blood flow: Studies are also looking at how terlipressin affects blood flow in the liver.
  • Managing ascites: Terlipressin may help reduce the accumulation of fluid in the abdomen (ascites) and decrease the need for procedures to remove this fluid.

Safety and Side Effects

As with any medication, terlipressin can have side effects. The safety of terlipressin is closely monitored in clinical trials. Some studies are specifically designed to assess the safety and tolerability of the drug. Potential side effects and safety concerns are typically evaluated through:

  • Physical examinations
  • Laboratory safety tests
  • Monitoring for adverse events

It's important to note that the full range of potential side effects may not be known, especially for new uses or administration methods being studied in clinical trials. Always discuss potential risks and benefits with your healthcare provider.

Questions people often ask

Conditions where Terlipressin Acetate is being studied

Each condition opens its own overview and trial list

Trials with Terlipressin Acetate

Recruiting trials first

See all 2 →
Quick filters
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).